Retatrutide (10mg)

Retatrutide — GIP/GLP-1/Glucagon receptor triple agonist research peptide. ≥99% HPLC purity, lyophilized vial, batch-specific lab report. For research use only.

• Compound: Retatrutide (LY3437943)
• Sequence: Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C18 fatty diacid-γ-Glu-AEEA-AEEA)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂
• Molecular Formula: C₂₂₁H₃₄₂N₅₆O₆₈
• Molecular Weight: ~4733 g/mol
• Purity: ≥99% (HPLC tested)
• Form: Lyophilized powder, sterile vial
• Quantity: 5mg or 10mg per vial

Retatrutide is a synthetic 39-amino-acid peptide function-engineered as a single-peptide triple agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors. It is studied in non-clinical laboratory research investigating multi-receptor metabolic synergy, lipolysis pathways, and energy expenditure models. Retatrutide is commonly studied alongside Tirzepatide and Semaglutide in comparative metabolic research protocols.

Storage: Store at 2°C to 8°C (36°F to 46°F) after reconstitution. Keep out of direct sunlight for maximum peptide stability. Reconstitute with bacteriostatic water for laboratory research. Typical: 2mL bacteriostatic water yields a 2.5 mg/mL solution. Store lyophilized vials at 2–8°C (refrigerated). Reconstituted solution should be stored at 2–8°C and used within 30 days. Do not freeze.